« More Embedded Linux Market Highlights | Main | Embedded Linux Highlights »

12/28/2005

Software Problems Shake Up Guidant/J&J Merger

How expensive is embedded software? At one point, software bugs were going to cost Guidant $6.4 Billion (sic). There were some manufacturing problems as well, so it was not just software. But software problems were a major contributor to the company's decline in value and subsequently the lower value of J&J's acquisition offer. Now Boston Scientific is offering $25 Billion so the loss may only be $400 Million. Still a lot of money.

The software is question is in Guidant's implantable heart defibrillator product. Apparently the problem is that the devices stop working. Sounds pretty serious. Amazingly, the company did not warn doctors about the problem right away. The FDA does not like that. We write a great deal about the importance of embedded software on device performance and company performance as well. Unfortunately it takes a major event for folks in the upper ranges of management to see light as well. Bet that $6.4 Billion woke them up.

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0115714871cc970c0120a6a12fc0970b

Listed below are links to weblogs that reference Software Problems Shake Up Guidant/J&J Merger:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Comments are moderated, and will not appear until the author has approved them.